NCT02565134View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus

PHASE2CompletedINTERVENTIONAL
Enrollment

296

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

July 31, 2016

Conditions
Skin Pruritus
Interventions
DRUG

PAC-14028 cream 0.1%

Topical application

DRUG

PAC-14028 cream 0.3%

Topical application

DRUG

PAC-14028 cream 1.0%

Topical application

DRUG

PAC-14028 cream vehicle

Topical application

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Amorepacific Corporation

INDUSTRY

NCT02565134 - A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus | Biotech Hunter | Biotech Hunter